메뉴 건너뛰기




Volumn 102, Issue 3, 2003, Pages 981-986

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TRANSCRIPTION FACTOR GATA 1;

EID: 0042243593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3599     Document Type: Article
Times cited : (257)

References (39)
  • 1
    • 0036156276 scopus 로고    scopus 로고
    • Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: Does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
    • Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24:2-5.
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 2-5
    • Gamis, A.S.1    Hilden, J.M.2
  • 3
    • 0025819483 scopus 로고
    • Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome
    • Kurahashi H, Hara J, Yumura-Yagi K, et al. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood. 1991;77:1161-1163.
    • (1991) Blood , vol.77 , pp. 1161-1163
    • Kurahashi, H.1    Hara, J.2    Yumura-Yagi, K.3
  • 4
    • 0036156452 scopus 로고    scopus 로고
    • Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome
    • Holt SE, Brown EJ, Zipursky A. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. J Pediatr Hematol Oncol. 2002;24;14-17.
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 14-17
    • Holt, S.E.1    Brown, E.J.2    Zipursky, A.3
  • 5
    • 0033780541 scopus 로고    scopus 로고
    • The management of neoplastic disorders of haematopoiesis in children with Down's syndrome
    • Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol. 2000;110:512-524.
    • (2000) Br J Haematol , vol.110 , pp. 512-524
    • Lange, B.1
  • 7
    • 0023459992 scopus 로고
    • Megakaryoblastic leukemia and Down's syndrome: A review
    • Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol. 1987;4:211-230.
    • (1987) Pediatr Hematol Oncol , vol.4 , pp. 211-230
    • Zipursky, A.1    Peeters, M.2    Poon, A.3
  • 8
    • 0035412104 scopus 로고    scopus 로고
    • Pattern of malignant disorders in individuals with Down's syndrome
    • Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2001;2:429-436.
    • (2001) Lancet Oncol , vol.2 , pp. 429-436
    • Hasle, H.1
  • 9
    • 0036153956 scopus 로고    scopus 로고
    • Down syndrome, transient myeloproliferative syndrome, and leukemia: Bridging development and neoplasia
    • Arceci RJ. Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasia. J Pediatr Hematol Oncol. 2002;24:1
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 1
    • Arceci, R.J.1
  • 10
    • 7844233319 scopus 로고    scopus 로고
    • Cytogenetic and molecular study of 32 Down syndrome families: Potential leukaemia predisposing role of the most proximal segment of chromosome 21q
    • Cavani S, Perfumo C, Argusti A, et al. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q. Br J Haematol. 1998;103:213-216.
    • (1998) Br J Haematol , vol.103 , pp. 213-216
    • Cavani, S.1    Perfumo, C.2    Argusti, A.3
  • 11
    • 0033991491 scopus 로고    scopus 로고
    • The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome
    • Malkin D, Brown EJ, Zipursky A. The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genet Cytogenet. 2000;116:1-5.
    • (2000) Cancer Genet Cytogenet , vol.116 , pp. 1-5
    • Malkin, D.1    Brown, E.J.2    Zipursky, A.3
  • 12
    • 0036636857 scopus 로고    scopus 로고
    • Core-binding factors in haematopoiesis and leukaemia
    • Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002;2:502-513.
    • (2002) Nat Rev Cancer , vol.2 , pp. 502-513
    • Speck, N.A.1    Gilliland, D.G.2
  • 13
    • 0034667690 scopus 로고    scopus 로고
    • High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired tdsomy 21
    • Preudhomme C, Warot-Loze D, Roumier C, et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired tdsomy 21. Blood. 2000; 96:2862-2869.
    • (2000) Blood , vol.96 , pp. 2862-2869
    • Preudhomme, C.1    Warot-Loze, D.2    Roumier, C.3
  • 14
    • 0032830638 scopus 로고    scopus 로고
    • Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
    • Song WJ, Sullivan MG, Legare RD, et al. Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166-175.
    • (1999) Nat Genet , vol.23 , pp. 166-175
    • Song, W.J.1    Sullivan, M.G.2    Legare, R.D.3
  • 15
    • 0036736555 scopus 로고    scopus 로고
    • Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome
    • Taketani T, Taki T, Takita J, et al. Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome. Leukemia. 2002;16:1866-1867.
    • (2002) Leukemia , vol.16 , pp. 1866-1867
    • Taketani, T.1    Taki, T.2    Takita, J.3
  • 16
    • 17344368548 scopus 로고    scopus 로고
    • CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome
    • Legare RD, Lu D, Gallagher M, et al. CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome. Leukemia. 1997;11:2111-2119.
    • (1997) Leukemia , vol.11 , pp. 2111-2119
    • Legare, R.D.1    Lu, D.2    Gallagher, M.3
  • 17
    • 0036727413 scopus 로고    scopus 로고
    • Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
    • Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148-152.
    • (2002) Nat Genet , vol.32 , pp. 148-152
    • Wechsler, J.1    Greene, M.2    McDevitt, M.A.3
  • 18
    • 0037071383 scopus 로고    scopus 로고
    • Transcriptional regulation of erythropoiesis: An affair involving multiple partners
    • Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368-3376.
    • (2002) Oncogene , vol.21 , pp. 3368-3376
    • Cantor, A.B.1    Orkin, S.H.2
  • 19
    • 0032227812 scopus 로고    scopus 로고
    • Transcription factor GATA-1 in megakaryocyte development
    • Orkin SH, Shivdasani RA, Fujiwara Y, McDevitt MA. Transcription factor GATA-1 in megakaryocyte development. Stem Cells. 1998;16(suppl 2):79-83.
    • (1998) Stem Cells , vol.16 , Issue.SUPPL. 2 , pp. 79-83
    • Orkin, S.H.1    Shivdasani, R.A.2    Fujiwara, Y.3    McDevitt, M.A.4
  • 20
    • 0034812344 scopus 로고    scopus 로고
    • Molecular and transcriptional regulation of megakaryocyte differentiation
    • Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001;19:397-407.
    • (2001) Stem Cells , vol.19 , pp. 397-407
    • Shivdasani, R.A.1
  • 21
    • 0030926006 scopus 로고    scopus 로고
    • A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development
    • Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965-3973.
    • (1997) EMBO J , vol.16 , pp. 3965-3973
    • Shivdasani, R.A.1    Fujiwara, Y.2    McDevitt, M.A.3    Orkin, S.H.4
  • 22
    • 0037081819 scopus 로고    scopus 로고
    • Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
    • Freson K, Matthijs G, Thys C, et al. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet. 2002;11:147-152.
    • (2002) Hum Mol Genet , vol.11 , pp. 147-152
    • Freson, K.1    Matthijs, G.2    Thys, C.3
  • 23
    • 0034052854 scopus 로고    scopus 로고
    • Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
    • Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266-270.
    • (2000) Nat Genet , vol.24 , pp. 266-270
    • Nichols, K.E.1    Crispino, J.D.2    Poncz, M.3
  • 24
    • 0037105495 scopus 로고    scopus 로고
    • X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction
    • Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100:2040-2045.
    • (2002) Blood , vol.100 , pp. 2040-2045
    • Yu, C.1    Niakan, K.K.2    Matsushita, M.3    Stamatoyannopoulos, G.4    Orkin, S.H.5    Raskind, W.H.6
  • 25
    • 0029558618 scopus 로고
    • Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor
    • Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C. Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci U S A. 1995;92:11598-11602.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 11598-11602
    • Calligaris, R.1    Bottardi, S.2    Cogoi, S.3    Apezteguia, I.4    Santoro, C.5
  • 26
    • 19044395448 scopus 로고    scopus 로고
    • Molecular analysis of the APC gene in 71 Israeli families: 17 Novel mutations
    • Gavert N, Yaron Y, Naiman T, et al. Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat. 2002;19:664.
    • (2002) Hum Mutat , vol.19 , pp. 664
    • Gavert, N.1    Yaron, Y.2    Naiman, T.3
  • 27
    • 0036841169 scopus 로고    scopus 로고
    • Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia
    • Bodamer OA, Bercovich D, Schlabach M, Ballantyne C, Zoch D, Beaudet AL. Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem. 2002;48:1913-1918.
    • (2002) Clin Chem , vol.48 , pp. 1913-1918
    • Bodamer, O.A.1    Bercovich, D.2    Schlabach, M.3    Ballantyne, C.4    Zoch, D.5    Beaudet, A.L.6
  • 28
    • 0034764037 scopus 로고    scopus 로고
    • Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis
    • Karandikar NJ, Aquino DB, McKenna RW, Kroft SH. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am J Clin Pathol. 2001;116:204-210
    • (2001) Am J Clin Pathol , vol.116 , pp. 204-210
    • Karandikar, N.J.1    Aquino, D.B.2    McKenna, R.W.3    Kroft, S.H.4
  • 29
    • 0032941980 scopus 로고    scopus 로고
    • Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome
    • Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19:157-167,vii.
    • (1999) Clin Lab Med , vol.19 , pp. 157-167
    • Zipursky, A.1    Brown, E.J.2    Christensen, H.3    Doyle, J.4
  • 30
    • 0036153957 scopus 로고    scopus 로고
    • Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study
    • Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2002;24:9-13.
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 9-13
    • Al-Kasim, F.1    Doyle, J.J.2    Massey, G.V.3    Weinstein, H.J.4    Zipursky, A.5
  • 31
    • 0036046660 scopus 로고    scopus 로고
    • Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins
    • Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Haematol. 2002;118: 1082-1086.
    • (2002) Br J Haematol , vol.118 , pp. 1082-1086
    • Stark, B.1    Jeison, M.2    Preudhomme, C.3
  • 33
    • 0033049402 scopus 로고    scopus 로고
    • Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome
    • Ma SK, Lee AC, Wan TS, Lam CK, Chan LC. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome. Leukemia. 1999;13:491-492.
    • (1999) Leukemia , vol.13 , pp. 491-492
    • Ma, S.K.1    Lee, A.C.2    Wan, T.S.3    Lam, C.K.4    Chan, L.C.5
  • 34
    • 0035106116 scopus 로고    scopus 로고
    • Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome
    • Ma SK, Wan TS, Chan GC, Ha SY, Fung LF, Chan LC. Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome. Br J Haematol. 2001;112:824-825.
    • (2001) Br J Haematol , vol.112 , pp. 824-825
    • Ma, S.K.1    Wan, T.S.2    Chan, G.C.3    Ha, S.Y.4    Fung, L.F.5    Chan, L.C.6
  • 35
    • 0037100420 scopus 로고    scopus 로고
    • Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): A study of the Groupe Francais de Cytogenetique Hematologique (GFCH)
    • Dastugue N, Lafage-Pochitaloff M, Pages MP, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood. 2002;100:618-626.
    • (2002) Blood , vol.100 , pp. 618-626
    • Dastugue, N.1    Lafage-Pochitaloff, M.2    Pages, M.P.3
  • 37
    • 0036725138 scopus 로고    scopus 로고
    • A leukemogenic twist for GATA1
    • Look AT. A leukemogenic twist for GATA1. Nat Genet. 2002;32:83-84.
    • (2002) Nat Genet , vol.32 , pp. 83-84
    • Look, A.T.1
  • 38
    • 0035093813 scopus 로고    scopus 로고
    • Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia
    • Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/ enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27: 263-270.
    • (2001) Nat Genet , vol.27 , pp. 263-270
    • Pabst, T.1    Mueller, B.U.2    Zhang, P.3
  • 39
    • 0036720398 scopus 로고    scopus 로고
    • The roles of FLT3 in hematopoiesis and leukemia
    • Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100: 1532-1542.
    • (2002) Blood , vol.100 , pp. 1532-1542
    • Gilliland, D.G.1    Griffin, J.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.